Cite
HARVARD Citation
Harshman, L. et al. (n.d.). 807PFirst interim results of the radium-223 (Ra-223) REASSURE observational study: Analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza). Annals of oncology. p. . [Online].